Millions Logo
home>US Stocks>BioHarvest Sciences
BHST
BioHarvest SciencesConsumer Defensive
$1.57$-5.31 (-77.19%)in 1 year
As on 13 Nov 2026 at 02:29NASDAQ
52 Week Low: $1.3752 Week High: $8.30

BioHarvest Sciences Share Price Today

BioHarvest Sciences opened at $1.75, in line with its previous close of $1.75. In the last trading session, the stock traded between $1.45 and $1.85. It showed a downward intraday trend.

Return calculator

Time Period

An investment of $100 made 2 years ago in BioHarvest Sciences is now worth

$ 27.29

Resulting in a loss of

$ 72.71 (72.71%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Buy

Rating from 4 Analysts

Buy
100%
Hold
0%
Sell
0%

Markets Today

Today's Change

$-0.18 (-10.34%)

Day High

$1.85

Day Low

$1.45

Day Open

$1.75

Prev Close

$1.75

Volume

1,19,386

1W Return

7.10%

1M Return

-3.74%

3M Return

-28.16%

6M Return

-57.48%

1Y Return

-77.19%

Fundamentals

Market Cap ($ Mn)

36

PE Ratio

-

PB Ratio

1.80

PEG Ratio

-

ROE

-189.28%

ROCE

-46.06%

EPS (TTM)

$-0.16

Investment Returns

1 Week

7.10%

1 Month

-3.74%

3 Months

-28.16%

6 Months

-57.48%

9 Months

-67.65%

Financials

Quarterly
All values in $ Mn
7.9

Mar 25
8.5

Jun 25
9.1

Sep 25
9.1

Dec 25
8.5

Mar 26
8.8

Jun 26

Updates

13Oct

BioHarvest Sciences' olive cell asset attains commercial readiness

Proprietary olive-derived Verbascoside composition attained commercial readiness. Asset completed development, manufacturing, and self-affirmed GRAS process. Ready for production at GMP facility and available for licensing. Demonstrates dose-dependent preclinical activity in liver steatosis models.

1mo ago
12Aug

BioHarvest Sciences cuts FY26 sales guidance to $37-40 million

BioHarvest Sciences reduces its FY26 revenue guidance to $37-40 million, below the $42.914 million estimate, driven by lower VINIA D2C and tightened CDMO segment forecasts.

3mo ago
11Aug

BioHarvest secures $20-30M deal for rare fragrance supply

BioHarvest Sciences Inc enters an exclusive manufacturing agreement for a rare, endangered fragrance plant cell culture, targeting $20-$30 million in revenue. Production of 20 metric tons begins in H1 2027, leveraging the company's proprietary Botanical Synthesis technology.

3mo ago
15Jul

BioHarvest Sciences secures $1.4M grant from Israel Innovation Authority

BioHarvest Sciences Inc received a 4.33 million NIS (approximately USD $1.4 million) grant from the Israel Innovation Authority to integrate advanced data science and machine learning into its workflows. The non-dilutive funding aims to accelerate plant cell culture programs and enhance sustainable molecule development.

4mo ago

Similar Stocks

StockLTPChange %Market CapPE
$167.67-0.59%$3,88,622.68M21.72
$65.78-1.04%$1,61,399.85M13.15
$66.70+0.24%$84,431.39M22.93
$98.00-0.09%$77,902.26M35.73
$108.86-1.72%$66,800.85M21.61
$70.92+2.34%$33,752.18M22.34
$24.27+0.12%$28,731.53M-
$112.33-0.97%$27,837.96M206.78
$112.02+0.23%$26,440.30M32.46
$176.43+1.43%$25,823.53M24.46
$100.28+0.87%$19,268.20M23.00
$34.21-1.13%$18,291.64M-